Detailed information for compound 1407012

Basic information

Technical information
  • TDR Targets ID: 1407012
  • Name: 4-amino-7-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hyd roxymethyl)oxolan-2-yl]-6-hydrazinylpyrrolo[5 ,4-d]pyrimidine-5-carboxamide
  • MW: 339.307 | Formula: C12H17N7O5
  • H donors: 7 H acceptors: 6 LogP: -2.34 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1c2ncnc(c2c(c1NN)C(=O)N)N
  • InChi: 1S/C12H17N7O5/c13-8-4-5(9(14)23)11(18-15)19(10(4)17-2-16-8)12-7(22)6(21)3(1-20)24-12/h2-3,6-7,12,18,20-22H,1,15H2,(H2,14,23)(H2,13,16,17)/t3-,6-,7+,12-/m1/s1
  • InChiKey: XCAQHWQRKUEFKS-GCGRGIBYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 4-amino-7-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-6-hydrazino-pyrrolo[5,4-d]pyrimidine-5-carboxamide
  • 4-amino-7-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-6-hydrazino-5-pyrrolo[5,4-d]pyrimidinecarboxamide
  • 4-amino-7-[(2R,3S,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-6-hydrazino-pyrrolo[5,4-d]pyrimidine-5-carboxamide
  • 4-amino-7-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-hydrazinyl-pyrrolo[5,4-d]pyrimidine-5-carboxamide
  • NCGC00014536
  • NSC-188491

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi hypothetical protein Get druggable targets OG5_131074 All targets in OG5_131074
Brugia malayi hypoxia-induced factor 1 Get druggable targets OG5_131074 All targets in OG5_131074
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131074 All targets in OG5_131074
Loa Loa (eye worm) hypoxia-induced factor 1 Get druggable targets OG5_131074 All targets in OG5_131074
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Brugia malayi hypothetical protein 0.0197 0.0608 0.0608
Chlamydia trachomatis two component regulatory system sensor histidine kinase 0.0106 0.0006 0.5
Loa Loa (eye worm) matrixin family protein 0.0179 0.0486 0.0101
Brugia malayi Matrixin family protein 0.0179 0.0486 0.0486
Schistosoma mansoni pyruvate dehydrogenase 0.1533 0.9405 0.9405
Brugia malayi hypoxia-induced factor 1 0.0182 0.0508 0.0508
Loa Loa (eye worm) hypoxia-induced factor 1 0.0182 0.0508 0.0123
Onchocerca volvulus Matrilysin homolog 0.0164 0.0389 1
Onchocerca volvulus Matrix metalloproteinase homolog 0.0164 0.0389 1
Toxoplasma gondii ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein 0.0658 0.3642 1
Schistosoma mansoni matrix metallopeptidase-9 (M10 family) 0.0175 0.0465 0.0465
Loa Loa (eye worm) hypothetical protein 0.0197 0.0608 0.0228
Schistosoma mansoni pyruvate dehydrogenase 0.1533 0.9405 0.9405

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) = 0.1585 um PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ] ChEMBL. No reference
Potency (functional) = 0.1585 um PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 914 ] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.